Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Summary Review
  • Published:

How effective is toluidine blue for screening and diagnosis of oral cancer and premalignant lesions?

Evidence-Based Dentistry volume 23, pages 34–35 (2022)Cite this article

Abstract

Design A systematic review and bivariate meta-analysis was designed to determine the efficacy of toluidine blue (TB) in the screening and diagnosis of oral cancer and premalignant lesions. Six databases were reviewed independently by two authors to identify relevant studies.

Case selection Inclusion criteria comprised prospective or retrospective studies comparing TB with chemiluminescence or clinical examination, which incorporated sensitivity and specificity analyses. Studies regarding diagnosis of non-oral tumours were excluded, as well as case reports and review articles.

Data analysis Diagnostic accuracy was analysed using diagnostic odds ratio (DOR) with 95% confidence intervals (CI). Summary receiver operating characteristic (SROC) curves and the inter-rater agreement were also analysed. Cohen's kappa coefficient and Fisher z-values were used to estimate reliability and stabilise variance. Homogeneity analyses were performed using the Q statistic. Forest plots were drawn for the sensitivity, specificity, negative predictive values, and SROC curves.

Results Twenty-nine studies comprising 1,921 participants were included in the meta-analysis. The DOR of TB was 7.017 (95% CI, 4.544; 10.836). Nine studies compared TB with chemiluminescence; TB had a lower sensitivity but a higher specificity. Compared with clinical examination in four studies, TB had a higher sensitivity and specificity. TB has a sensitivity of 73% and specificity of 69%, and was found to be more sensitive in severe dysplasia but more specific in benign lesions.

Conclusions The diagnostic accuracy of TB for oral cancer or premalignant lesions is greater than clinical examination alone; however, it is not reliable enough for TB to be used as a screening method in isolation. TB is a diagnostic aid that can be recommended in adjunct with chemiluminescence or other techniques.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Jemal A, Bray F, Centre M M, Ferlay J, Ward E, Forman D. Global Cancer Statistics. CA Cancer J Clin 2011; 61: 69-90.

  2. Johnson N W, Jayasekara P, Amarasinghe A A. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000 2011; 57: 19-37.

  3. Sankaranarayanan R, Nair M K, Mathew B, Balaram P, Sebastian P, Dutt S C. Recent results of oral cancer research in Kerala, India. Head Neck 1992; 114: 107-112.

  4. Adil H A, Yuwanati M, Singh A, Sawant S, Umarji H R. Comparative study on the efficacy of Tissue Autofluorescence (Visually Enhanced Lesion Scope) and Toluidine Blue as a screening method in oral potentially malignant and malignant lesions. J Med Sci 2017; 37: 91-96.

  5. Jitender S, Sarika G, Varada H R, Omprakash Y, Mohsin K. Screening for oral cancer. J Exp Ther Oncol 2016; 11: 303-307.

  6. Rahman F, Tippu S R, Khandelwal S, Girish K L, Manjunath B C, Bhargava A. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions. Quintessence Int 2012; 43: 51-59.

  7. Thirunavukarasu S, Mathew P, Austin R D, Srivastava K C, Ramasamy S, Usha V. Efficacy of toluidine blue, lugol's iodine and acetic acid for detecting oral lesions of leukoplakia and erosive lichen planus - a cross-sectional study. J Ind Acad Oral Med Radiol 2020; 32: 253-258.

  8. Rajmohan M, Rao U K, Joshua E, Rajasekaran S T, Kannan R. Assessment of oral mucosa in normal, precancer and cancer using chemiluminescent illumination, toluidine blue supravital staining and oral exfoliative cytology. J Oral Maxillofac Pathol 2012; 16: 325-329.

  9. Epstein J B, Scully C, Spinelli J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992; 21: 160-163.

  10. Sridharan G, Shankar A A. Toluidine blue: A review of its chemistry and clinical utility. J Oral Maxillofac Pathol 2012; 16: 251-255.

  11. Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol 1989; 67: 621-627.

Download references

Author information

Authors and Affiliations

  1. Oral and Maxillofacial Surgery Department, Norfolk and Norwich University Hospital, Norwich, UK

    Sophie Mills

Authors
  1. Sophie Mills
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mills, S. How effective is toluidine blue for screening and diagnosis of oral cancer and premalignant lesions?. Evid Based Dent 23, 34–35 (2022). https://doi.org/10.1038/s41432-022-0239-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41432-022-0239-x

Search

Advanced search

Quick links